Pharmaceutical manufacturers of Hydroxyethyl starch

Fresenius Kabi operates as an international healthcare organization specializing in essential medications and advanced technologies for intravenous therapy, blood transfusion, and medical nourishment. The company's portfolio is instrumental in supporting the needs of severely and persistently unwell individuals. Additionally, it provides a variety of active pharmaceutical ingredients (APIs) and finalized goods fabricated within its own establishments

Fresenius is an international healthcare conglomerate offering products and services for kidney dialysis, hospital care, and home medical treatment. The Fresenius Group comprises four distinct business segments - Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed - each managing its own global operations.

Swati Spentose (SSPL) is a technology-driven manufacturing company specializing in the production and supply of both APIs & FDFs. Swati Spentose Pvt. Ltd. (SSPL) Unit 1 has been inspected by USFDA, certified by EU-GMP, approved by COFEPRIS in Mexico & MFDS in Korea, and WHO-GMP certified (www.spentose.com). They offer products such as Polysaccharide Block-Pentosan Polysulfate Sodium (PPS), Multipurpose Block-Lidocaine Base/HCl, Meloxicam, Melatonin, Granisetron Base/HCl, Prilocaine Base/HCL, Glycopyrrolate, Tamsulosin, Silodosin, Mirabegron. SSPL Unit-2 details are not provided.

Wuhan HUST Life Science & Technology Co Ltd, a pharmaceutical enterprise jointly funded by Wuhan HUST High-Tech Group Ltd, Wuhan Huagong Venture Capital Co Ltd and Wuhan HUST Nano Medicine Co Ltd, was established in June 2005. The company specializes in the manufacturing, distribution, import and export of active pharmaceutical ingredients, intermediates, preparations, and chemical products, with a focus on researching and developing innovative pharmaceutical solutions.